Table 1.
Patient and Procedure Characteristics According to Study Group
| Characteristic | Group D (n = 30) | Group S (n = 30) | P value |
|---|---|---|---|
| Sex (n, male/female) | 16/14 | 13/17 | 0.273* |
| Age (years) | 54.4±4.8 | 56.0±3.9 | 0.175# |
| BMI (kg/m2) | 21.5±1.2 | 20.9±1.4 | 0.102# |
| ASA classification (n, I/II) | 17/13 | 12/18 | 0.801* |
| Anaesthesia time (min) | 193.0±20.2 | 203.4±22.1 | 0.064# |
| Operative time (min) | 171.2±14.2 | 177.7±26.2 | 0.232# |
| Intraoperative sufentanil dosage (μg) | 55.7±23.0 | 48.6±17.4 | 0.178# |
| Postoperative emergency sufentanil dosage (μg) | 5.2±0.5 | 5.4±0.9 | 0.195# |
| Remifentanil dosage (μg) | 1143.3±229.5 | 1007.3±198.8 | 0.519# |
Notes: Values are presented as mean ± SD or numbers of patients. *Fisher’s exact test for statistical analysis. #Independent samples t-test for statistical analysis.